AAAAAA

   
Results: 1-15 |
Results: 15
Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene
Authors: Chalmers, D Ferrand, C Apperley, JF Melo, JV Ebeling, S Newton, I Duperrier, A Hagenbeek, A Garrett, E Tiberghien, P Garin, M
Citation: D. Chalmers et al., Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene, MOL THER, 4(2), 2001, pp. 146-148
Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma
Authors: de Weerdt, O van de Donk, NWCJ Veth, G Bloem, AC Hagenbeek, A Lokhorst, HM
Citation: O. De Weerdt et al., Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma, NETH J MED, 59(2), 2001, pp. 50-56
A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies
Authors: Buijs, A Poddighe, P van Wijk, R van Solinge, W Borst, E Verdonck, L Hagenbeek, A Pearson, P Lokhorst, H
Citation: A. Buijs et al., A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies, BLOOD, 98(9), 2001, pp. 2856-2858
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations
Authors: Broeks, A Russell, NS Floore, AN Urbanus, JHM Dahler, EC van't Veer, MB Hagenbeek, A Noordijk, EM Crommelin, MA van Leeuwen, FE van't Veer, LJ
Citation: A. Broeks et al., Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations, INT J RAD B, 76(5), 2000, pp. 693-698
Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide ordaunomycin are equally sensitive to the drug acetyldinaline as the parental cell line
Authors: El-Beltagi, HM Martens, ACM Hagenbeek, A
Citation: Hm. El-beltagi et al., Leukemia cell lines resistant to cytosine arabinoside, cyclophosphamide ordaunomycin are equally sensitive to the drug acetyldinaline as the parental cell line, LEUKEMIA, 14(1), 2000, pp. 213-214
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
Authors: van Leeuwen, FE Klokman, WJ van't Veer, MB Hagenbeek, A Krol, ADG Vetter, UAO Schaapveld, M van Heerde, P Burgers, JMV Somers, R Aleman, BMP
Citation: Fe. Van Leeuwen et al., Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood, J CL ONCOL, 18(3), 2000, pp. 487-497
Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia
Authors: Martens, ACM Hagenbeek, A
Citation: Acm. Martens et A. Hagenbeek, Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia, EUR J CANC, 35(4), 1999, pp. 634-640
International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury
Authors: Shipp, MA Abeloff, MD Antman, KH Carroll, G Hagenbeek, A Loeffler, M Montserrat, E Radford, JA Salles, G Schmitz, N Symann, M Armitage, JO Coiffier, B Philip, T
Citation: Ma. Shipp et al., International Consensus Conference on High-Dose Therapy with HematopoieticStem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report ofjury, ANN ONCOL, 10(1), 1999, pp. 13-19
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
Authors: Cheson, BD Horning, SJ Coiffier, B Shipp, MA Fisher, RI Connors, JM Lister, TA Vose, J Grillo-Lopez, A Hagenbeek, A Cabanillas, F Klippensten, D Hiddemann, W Castellino, R Harris, NL Armitage, JO Carter, W Hoppe, R Canellos, GP
Citation: Bd. Cheson et al., Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas, J CL ONCOL, 17(4), 1999, pp. 1244-1253
International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury
Authors: Shipp, MA Abeloff, MD Antman, KH Carroll, G Hagenbeek, A Loeffler, M Montserrat, E Radford, JA Salles, G Schmitz, N Symann, M Armitage, JO Philip, T Coiffier, B
Citation: Ma. Shipp et al., International consensus conference on high-dose therapy with hematopoieticstem cell transplantation in aggressive non-hodgkin's lymphomas: Report ofthe jury, J CL ONCOL, 17(1), 1999, pp. 423-429
Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?
Authors: Vellenga, E van Putten, WLJ Boogaerts, MA Daenen, SMGJ Verhoef, GEG Hagenbeek, A Jonkhoff, AR Huijgens, PC Verdonck, LF van der Lelie, J Schouten, HC Gmur, J Wijermans, P Gratwohl, A Hess, U Fey, MF Lowenberg, B
Citation: E. Vellenga et al., Peripheral blood stem cell transplantation as an alternative to autologousmarrow transplantation in the treatment of acute myeloid leukemia?, BONE MAR TR, 23(12), 1999, pp. 1279-1282
Reverse chromosome painting for the identification of marker chromosomes and complex translocations in leukemia
Authors: Arkesteijn, G Jumelet, E Hagenbeek, A Smit, E Slater, R Martens, A
Citation: G. Arkesteijn et al., Reverse chromosome painting for the identification of marker chromosomes and complex translocations in leukemia, CYTOMETRY, 35(2), 1999, pp. 117-124
Non-Hodgkin's lymphomas
Authors: Hagenbeek, A Kluin, PM
Citation: A. Hagenbeek et Pm. Kluin, Non-Hodgkin's lymphomas, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 635-684
GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF
Authors: Rozemuller, H Terpstra, W Rombouts, EJC Lawler, M Byrne, C FitzGerald, DJP Kreitman, RJ Wielenga, JJ Lowenberg, B Touw, IP Hagenbeek, A Martens, ACM
Citation: H. Rozemuller et al., GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF, LEUKEMIA, 12(12), 1998, pp. 1962-1970
Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences
Authors: Havenga, MJE Vogels, R Braakman, E Kroos, N Valerio, D Hagenbeek, A van Es, HHG
Citation: Mje. Havenga et al., Second gene expression in bicistronic constructs using short synthetic intercistrons and viral IRES sequences, GENE, 222(2), 1998, pp. 319-327
Risultati: 1-15 |